JAK2 and neoplasm: Our analysis highlights that ASCETIC consistently identifies alterations in CALR, JAK2, and IDH1/2 genes as early events in tumor history, while NRAS represents an acquired secondary event, towards which evolutionary trajectories appear to converge during the progression of the disease.